ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Oncobayes Alpha Limited

Oncobayes Alpha Limited is an active company incorporated on 27 July 2021 with the registered office located in London, Greater London. Oncobayes Alpha Limited was registered 4 years ago.
Status
Active
Active since incorporation
Company No
13532839
Private limited company
Age
4 years
Incorporated 27 July 2021
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 26 July 2025 (1 month ago)
Next confirmation dated 26 July 2026
Due by 9 August 2026 (11 months remaining)
Last change occurred 27 days ago
Accounts
Submitted
For period 1 Aug31 Jul 2024 (1 year)
Accounts type is Micro Entity
Next accounts for period 31 July 2025
Due by 30 April 2026 (7 months remaining)
Contact
Address
71-75 Shelton Street
Covent Garden
London
WC2H 9JQ
United Kingdom
Same address since incorporation
Telephone
Unreported
Email
Unreported
Website
Unreported
People
Officers
5
Shareholders
55
Controllers (PSC)
1
Director • Director • Company Executive • British • Lives in UK • Born in Sep 1968
Director • Consultant • British • Lives in UK • Born in May 1981
Director • Pharmaceutical Consultant • British • Lives in England • Born in Dec 1987
Director • British • Lives in England • Born in Dec 1969
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Propagate Limited
Mark Edward Brimble is a mutual person.
Active
Globe Life Sciences Limited
Mark Edward Brimble is a mutual person.
Active
Propagate Pharma Limited
Mark Edward Brimble is a mutual person.
Active
Pre-Op Limited
Dr James Simon Millen is a mutual person.
Active
Mucora Therapeutics Ltd
Mark Edward Brimble is a mutual person.
Active
Oncobayes Limited
Dr Hitesh Mistry, Mark Edward Brimble, and 1 more are mutual people.
Dissolved
Financials
Net Assets, Total Assets & Total Liabilities (2022–2024)
Period Ended
31 Jul 2024
For period 31 Jul31 Jul 2024
Traded for 12 months
Cash in Bank
Unreported
Same as previous period
Turnover
Unreported
Same as previous period
Employees
1
Increased by 1 (%)
Total Assets
£260.57K
Increased by £259.69K (+29376%)
Total Liabilities
-£41.85K
Increased by £37.61K (+887%)
Net Assets
£218.72K
Increased by £222.07K (-6617%)
Debt Ratio (%)
16%
Decreased by 463.58% (-97%)
Latest Activity
Confirmation Submitted
27 Days Ago on 11 Aug 2025
Micro Accounts Submitted
4 Months Ago on 28 Apr 2025
Confirmation Submitted
1 Year 1 Month Ago on 29 Jul 2024
Mr Mark Edward Brimble Details Changed
1 Year 5 Months Ago on 20 Mar 2024
Mr Joshua James Fleet Details Changed
1 Year 5 Months Ago on 18 Mar 2024
Notification of PSC Statement
1 Year 5 Months Ago on 18 Mar 2024
James Millen (PSC) Resigned
1 Year 5 Months Ago on 13 Mar 2024
Hitesh Mistry (PSC) Resigned
1 Year 5 Months Ago on 13 Mar 2024
Mr Joshua James Fleet Appointed
1 Year 6 Months Ago on 8 Mar 2024
Micro Accounts Submitted
1 Year 6 Months Ago on 7 Mar 2024
Get Credit Report
Discover Oncobayes Alpha Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Confirmation statement made on 26 July 2025 with updates
Submitted on 11 Aug 2025
Statement of capital following an allotment of shares on 12 May 2025
Submitted on 13 May 2025
Micro company accounts made up to 31 July 2024
Submitted on 28 Apr 2025
Statement of capital following an allotment of shares on 10 March 2025
Submitted on 10 Mar 2025
Statement of capital following an allotment of shares on 7 January 2025
Submitted on 10 Jan 2025
Memorandum and Articles of Association
Submitted on 28 Nov 2024
Resolutions
Submitted on 28 Nov 2024
Statement of capital following an allotment of shares on 27 August 2024
Submitted on 27 Aug 2024
Confirmation statement made on 26 July 2024 with updates
Submitted on 29 Jul 2024
Statement of capital following an allotment of shares on 31 May 2024
Submitted on 6 Jun 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year